AMCP Market Insights: Managed care considerations in chronic inflammatory demyelinating polyradiculoneuropathy

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a progressive, immune-mediated syndrome of the peripheral nerves characterized by proximal and distal motor and sensory symptoms. Diagnostic delays and misdiagnosis are common with CIDP, and it is associated with significant disease and treatment burden. Evolving science has identified biomarkers driving diagnostic and treatment innovation in CIDP, warranting guidance for payers. To discuss managed care considerations in CIDP, AMCP Market Insights virtually convened an expert panel of managed care stakeholders in May 2026. This article provides a qualitative summary of the panel discussion along with key insights and suggested payer practices meant to support informed coverage decisions and guide future work such as collaboration, research, and advocacy. Two key insights identified were that diagnostic challenges and current treatment limitations are primary unmet needs in the care of patients with CIDP and payer management is focused on supporting timely, appropriate treatment to mitigate disease progression and increased health care resource utilization. Additionally, participants see potential value in emerging biomarkers and treatments with new mechanisms of action. Suggested payer practices include providing care management or other resources, aligning coverage criteria with clinical practice, and evolving CIDP management strategy based on advancing science.

Authors

Institutions

Publication Details

Journal
Journal of Managed Care & Specialty Pharmacy
Published
2026-11-17
DOI
https://doi.org/10.18553/jmcp.2026.32.12-a.s1
Primary Topic
Peripheral Neuropathies and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

AMCP Market Insights: Managed care considerations in chronic inflammatory demyelinating polyradiculoneuropathy

Ryan J. Haumschild, Ehtesham Khalid, Michael S. Kobernick, Bridget M. Flavin et al.
1 links
Journal of Managed Care & Specialty Pharmacy
Peripheral Neuropathies and Disorders
article

AMCP Market Insights: Managed care considerations in chronic inflammatory demyelinating polyradiculoneuropathy

Ryan J. Haumschild, Ehtesham Khalid, Michael S. Kobernick, Bridget M. Flavin, Terry Richardson, Adam Hoye-Simek, Hiva Pourarsalan, Charles Dragovich
article en

Abstract

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a progressive, immune-mediated syndrome of the peripheral nerves characterized by proximal and distal motor and sensory symptoms. Diagnostic delays and misdiagnosis are common with CIDP, and it is associated with significant disease and treatment burden. Evolving science has identified biomarkers driving diagnostic and treatment innovation in CIDP, warranting guidance for payers. To discuss managed care considerations in CIDP, AMCP Market Insights virtually convened an expert panel of managed care stakeholders in May 2026. This article provides a qualitative summary of the panel discussion along with key insights and suggested payer practices meant to support informed coverage decisions and guide future work such as collaboration, research, and advocacy. Two key insights identified were that diagnostic challenges and current treatment limitations are primary unmet needs in the care of patients with CIDP and payer management is focused on supporting timely, appropriate treatment to mitigate disease progression and increased health care resource utilization. Additionally, participants see potential value in emerging biomarkers and treatments with new mechanisms of action. Suggested payer practices include providing care management or other resources, aligning coverage criteria with clinical practice, and evolving CIDP management strategy based on advancing science.

Journal of Managed Care & Specialty PharmacyVol. 32(12-a Suppl)
Ochsner Health System (US), Emory University (US), CAE Solutions (United States) (US), Mercy Health (US)
Good health and well-being
Peripheral Neuropathies and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon